Results 71 to 80 of about 35,006 (266)

The real‐world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody‐associated disease criteria in a Latin American cohort

European Journal of Neurology, Volume 31, Issue 12, December 2024.
Abstract Background and Purpose The diagnostic criteria for myelin oligodendrocyte glycoprotein antibody (MOG‐IgG)‐associated disease (MOGAD) were published in 2023. We aimed to determine the performance of the new criteria in Latin American (LATAM) patients compared with the 2018 criteria and explore the significance of MOG–IgG titers in diagnosis ...
Edgar Carnero Contentti, Claudia Pestchanker, Ethel Ciampi, Sheila Castro Suarez, Cesar Caparo Zamalloa, Vanesa Daccach Marques, Katharina Messias, José Ignacio Gortari, Verónica Tkachuk, Berenice Silva, Carolina Mainella, Saúl Reyes, Jaime Toro, Juan Rodriguez, Edgar Correa‐Diaz, Juan I. Rojas, Friedemann Paul   +16 more
wiley   +1 more source

A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis

Neurología (English Edition), 2018
Introduction: Gait impairment, a frequent sign in multiple sclerosis (MS), places a major burden on patients since it results in progressive loss of personal and social autonomy, along with work productivity. This guide aims to provide recommendations on
L. Ramió-Torrentà, J.C. Álvarez-Cermeño, R. Arroyo, B. Casanova-Estruch, O. Fernández, J.A. García-Merino, M.A. Hernández, G. Izquierdo, S. Martínez-Yélamos, J. Meca, E. Moral, J. Olascoaga, J.M. Prieto, A. Saiz   +13 more
doaj   +1 more source

Esclerosis Tuberosa

Acta Pediátrica Hondureña, 2017
No hay ResumenActa Pediátrica Hondureña, Vol. 6, No.
Héctor Rubén Caballero Castro, Linda Julissa López Flores   +1 more
openaire   +2 more sources

Esclerosis lateral amiotrófica: actualización

IATREIA, 2016
Amyotrophic lateral sclerosis is a neurodegenerative disease with devastating consequences for the patient and his/her family. Its etiology is still not clear. In about 10 % of the patients there is a hereditary pattern of the disease. Worldwide, prevalence ranges from 2 to 11 cases per 100,000 people. Age of presentation varies from 58 to 63 years for
Zapata Zapata, Carlos Hugo, Franco Dáger, Edwing, Solano Atehortúa, Juan Marcos, Ahunca Velásquez, Luisa Fernanda   +3 more
openaire   +4 more sources

Effect of Sclerosis Bands in Femoral Head Necrosis on Non‐Vascularized Fibular Grafting—A Finite Element Study

Orthopaedic Surgery, Volume 16, Issue 10, Page 2526-2538, October 2024.
This study simulated the stress and displacement distribution on the surface of the femoral head after non‐vascularized fibular grafting surgery using a finite element model. The results indicated that the sclerosis band in the anterolateral region plays a mechanical supporting role for the femoral head after non‐vascularized fibular grafting surgery ...
Huang Yixuan, Yuan Xinwei, Gao Feifei, Mai Jianbin, Guo Mingbin, Xi Hongzhong, Song Wei, Liu Xin, Du Bin   +8 more
wiley   +1 more source

Empoderamiento y proactividad ante la Esclerosis Múltiple

Revista Española de Discapacidad, 2013
Esclerosis Múltiple España (2013): “Empoderamiento y proactividad ante la Esclerosis Múltiple”, Revista Española de Discapacidad, 1 (1): 225-231.
Esclerosis Múltiple España
doaj  

Insuficiencia venosa cerebroespinal crónica y esclerosis múltiple: revisión y actualización del tema [PDF]

, 2011
The aetiology of multiple sclerosis remains unknown at the present time, although the most likely explanation is that it has an autoimmune inflammatory origin. During the history of this disease a vascular pathophysiology was once proposed,
Gasca-Salas, C. (C.), Gomez-Ibañez, A. (Asier)   +1 more
core  

Esclerosis Lupoide

Acta Neurológica Colombiana, 2013
La esclerosis lupoide es una entidad de exclusión que reúne características fisiopatológicas, clínicas e imagenológicas comunes entre e lupus eritematoso sistémico (LES) y esclerosis múltiple (EM). El propósito del artículo es revisar aspectos inmunológicos, de laboratorio y diagnósticos diferenciales que faciliten comprobar la EL como una entidad ...
González Trujillo, Fernando, Medina, Yimy F, Lozano, Alfonso   +2 more
openaire   +3 more sources

Actualización: esclerosis múltiple [PDF]

Medifam, 2001
Desde que hace más de 100 años Carswell, Cruveilhier y especialmente Charcot que en 1868 ofrece la primera descripción detallada de lo que él llamó "esclerosis en placas", hasta la actualidad, la esclerosis múltiple sigue siendo un desafío para los investigadores y médicos que se dedican a tratarla.
Carretero Ares, J. L., Bowakim Dib, W., Acebes Rey, J. M.   +2 more
openaire   +3 more sources

Microscopic fractional anisotropy outperforms multiple sclerosis lesion assessment and clinical outcome associations over standard fractional anisotropy tensor

Human Brain Mapping, Volume 45, Issue 8, June 1, 2024.
This research reveals that microscopic fractional anisotropy outperforms standard fractional anisotropy in identifying tissue damage and discerning connectivity patterns in multiple sclerosis, thus improving lesion prediction and insight into the disease's cognitive and physical effects.
F. Vivó, E. Solana, A. Calvi, E. Lopez‐Soley, L. B. Reid, S. Pascual‐Diaz, C. Garrido, L. Planas‐Tardido, J. M. Cabrera‐Maqueda, S. Alba‐Arbalat, M. Sepulveda, Y. Blanco, B. Kanber, F. Prados, A. Saiz, S. Llufriu, E. Martinez‐Heras   +16 more
wiley   +1 more source